PsyBio Therapeutics Corp. announced that it has appointed Michael Spigarelli, M.D., Ph.D., MBA, as Chief Medical Officer to lead the ongoing development of PsyBio's drug discovery platform technology. Appointed Mr. Bob Oliver to the company's board of directors. Mr. Oliver served as President and Chief Executive Officer of Otsuka America Pharmaceutical.